| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $121.0M | — | +1.0% |
| Cost of Revenue | $19.0M | — | -0.9% |
| Gross Profit | $101.9M | — | +1.3% |
| R&D Expense | $30.0M | — | -11.9% |
| SG&A Expense | $23.2M | — | -13.7% |
| Operating Income | $9.2M | — | +188.9% |
| Pre-tax Income | $10.9M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $208.9M | -12.0% | -43.8% |
| Short-term Investments | $235.1M | +1.1% | +4.3% |
| Accounts Receivable | $76.0M | -29.9% | -4.6% |
| Current Assets | $559.0M | -8.7% | -21.6% |
| Total Assets | $936.6M | -5.4% | +1.1% |
| Current Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $44.3M | — | +44.4% |
| Capital Expenditures | $965K | — | +118.8% |
| Investing Cash Flow | -$5.1M | — | -201.6% |
| Financing Cash Flow | -$67.6M | — | -1609.4% |
| Free Cash Flow | $43.3M | — | +43.3% |
| +266.5% |
| Income Tax | $5.8M | — | +613.5% |
| Net Income | $5.3M | — | +173.8% |
| EPS (Basic) | $0.13 | — | +285.7% |
| EPS (Diluted) | $0.13 | — | +285.7% |
| $287.0M |
| -5.6% |
| -18.9% |
| Total Liabilities | $708.1M | -1.6% | -7.3% |
| Stockholders' Equity | $216.5M | -14.6% | +48.7% |